Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience


KILIÇ L. , KARADAĞ Ö. , Erden A., SARI A. , ARMAĞAN B. , YARDIMCI G. K. , ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.1, pp.31-36, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.3906/sag-1906-39
  • Title of Journal : TURKISH JOURNAL OF MEDICAL SCIENCES
  • Page Numbers: pp.31-36

Abstract

Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu's arteritis (TA) patients who are unresponsive to corticosteroids +/- conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety of anti-IL-6 (tocilizumab) therapy in refractory TA patients in real life.